Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-60
SponsorUniversity of Texas at Austin
About this trial
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Eligibility criteria
Qualifiers
Adult women (30-60 years)
Having overweight or obesity (BMI >25 kg/m2)
Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician
Willing and able to maintain current inactivity patterns throughout the study
Disqualifiers
Adults (<30 years or >60 years)
Having normal weight (BMI <25 kg/m2)
Not prescribed GLP-1 medication by a physician
Those on GLP-1 medication longer than 4 weeks (during time of screening)
Trial design
Treatments tested in this trial
- Protein Rich Foods
Treatment groups
75 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Texas at Austin
Lead sponsor
National Pork Board
Collaborator
Source ClinicalTrials.gov